Yahoo Finance Plus Israeli Prime Minister Benjamin Netanyahu’s coalition on Monday passed the first bill in a contentious judicial overhaul that seeks to limit the power of the Supreme Court. WSJ’s Dov Lieber reports from Jerusalem. Photo: Corinna Kern/Reuters
Charlie Munger of Berkshire Hathaway told CNBC just weeks ago that he would no longer bother with the bucket-list item in his old age.
Charlie Munger, the longtime business partner of Warren Buffett, said he lived in the same house for decades because he thought it'd be better for his kids.
Many older Americans are missing out on valuable tax breaks offered by the IRS, leaving behind savings that could make a difference for their financial well-being. “The reason this is happening is because the tax code is complicated, and rules on tax exemptions are constantly changing,” says Tom O’Saben, director of tax content and government relations at the National Association of Tax Professionals in Washington, D.C. “This makes it hard for the average taxpayer to know about the array of tax breaks available to them.” Together, these changes have brought new tax breaks, diminished the use of others, and otherwise muddled the tax-filing process.
There’s still plenty of yield in the stock market even with the recent rally that has resulted in a 19% year-to-date gain in the this year. Plenty of stocks have been left behind and many carry outsize yields of 6% or more—including a total of about 40 in the S&P 500 and S&P MidCap 400 indexes, according to data from S&P Dow Jones Indices. For Boston Properties and Healthpeak Properties, we are using funds from operations, a cash-flow measure used by real estate investment trusts, rather than earnings per share, which is lower for both companies.
Home prices will fall in 2024 for the first time in more than a decade, according to one industry forecaster—but declines won’t be uniform. Sales will remain low; the supply of available homes for sale will continue to slide; and mortgage rates will average 6.8% in the new year, according to Realtor.com’s forecast published on Wednesday. The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast.
Warren Buffett’s Berkshire Hathaway says the billionaire Haslam family tried to bribe at least 15 executives at the Pilot truck stop chain with millions of dollars to get them to inflate the company’s profits this year because that would force Berkshire to pay more for the Haslams’ remaining 20% stake in the company. The Berkshire claim in a counter lawsuit filed this week comes after the Haslam family — which includes Cleveland Browns owner Jimmy Haslam and former Tennessee governor Bill Haslam — accused Berkshire of trying to understate Pilot’s earnings this year by changing its accounting practices.
Microsoft joins OpenAI board, General Motors increases dividend and stock buybacks, Cigna and Humana discuss merger, and other news to start your day.
ImmunoGen stock was soaring Thursday following an announcement that biopharmaceutical company AbbVie has agreed to buy the cancer treatment developer for $10.1 billion. Under the terms of the sale agreement, AbbVie will acquire all outstanding shares of ImmunoGen for $31.26 a share. The transaction is subject to shareholder and regulatory approval.
A fresh 2023 closing high is in reach for stocks on Thursday as investors digest further data which show inflation is cooling.
Magnificent seven stocks have had a massive rally in 2023. Four are attracting fund managers and are near buy points.
Rental property ownership has its benefits, but selling can create a big tax hit. Thankfully, there are ways to reduce capital gains exposure.
Hope you didn't bail out of S&P 500 stocks after three-straight months of losses. November turned into a big moneymaker.
The late billionaire investor Charlie Munger was obsessed with Costco, personally owned its stock and served on the company's board of directors.
AbbVie is buying ImmunoGen in a deal valued at about $10.1 billion with the goal of speeding the pharmaceutical's entry into the market for ovarian cancer treatments. ImmunoGen Inc. developed the ovarian cancer drug Elahere, which AbbVie says it sees as a potential multibillion-dollar future revenue generator. "The acquisition of ImmunoGen demonstrates our commitment to deliver on our long-term growth strategy and enables AbbVie to further diversify our oncology pipeline across solid tumors and hematologic malignancies,” AbbVie Chairman and CEO Richard Gonzalez said in a statement on Thursday.
The concept of living off the interest and returns from a retirement account has become a focal point for many Americans. The common goal is to accumulate enough savings by their late 60s to enjoy a secure, indefinite retirement. For younger generations, the ambition often shifts toward amassing a substantial nest egg for early retirement. But reaching this milestone is not a simple task, prompting many to ponder: Is $1 million sufficient? And more importantly, is it feasible to live off the ret
The Tesla CEO and owner of social media platform X spoke at the New York Times 2023 Dealbook Summit Wednesday evening.
The Cigna-Humana merger will provide the combined body with increased negotiation power with healthcare providers, pharmaceutical companies and other stakeholders.
The company blamed the miss on a business model transition and the delayed fulfillment of a large customer order.
Big pharma’s [$10.1 billion deal splash](https://www.wsj.com/business/deals/abbvie-to-buy-immunogen-for-more-than-10-billion-5e942e18?mod=business_lead_pos2) is giving biotech stocks a lift. AbbVie, which sells widely-used drugs like Humira and Skyrizi, said Thursday it plans to buy cancer drug developer ImmunoGen for $31.
Paying a 1% annual fee to a financial advisor for managing a $2 million investment portfolio is pretty typical, but that doesn’t necessarily mean it’s the right amount for every investor. Even small-sounding financial advisor fees can seriously erode long-term returns when compounded over years or decades. A 1% annual fee on a $2 million […] The post I Have $2 Million Invested With My Financial Advisor and Pay a 1% Fee. Am I Paying Too Much? appeared first on SmartReads by SmartAsset.
Yahoo Finance